S&P 500 Futures Drop in Pre-Market Session; Valmont Industries and Loews Underperform
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Apr 07 2026
0mins
Should l Buy UNH?
Source: Barron's
Market Opening: U.S. stock markets are set to open in two hours.
Humana Inc. Performance: Humana Inc. (HUM) saw a 9.8% increase in pre-market trading.
Brookfield Wealth Solutions Performance: Brookfield Wealth Solutions Ltd. (BNT) experienced a 9.7% rise in pre-market trading.
Overall Market Sentiment: The significant gains in these stocks indicate positive market sentiment ahead of the market opening.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy UNH?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on UNH
Wall Street analysts forecast UNH stock price to rise
19 Analyst Rating
16 Buy
3 Hold
0 Sell
Strong Buy
Current: 370.750
Low
330.00
Averages
397.82
High
444.00
Current: 370.750
Low
330.00
Averages
397.82
High
444.00
About UNH
UnitedHealth Group Incorporated is a healthcare and well-being company. Its segments include Optum Health, Optum Insight, Optum Rx, and UnitedHealthcare, which includes UnitedHealthcare Employer & Individual, UnitedHealthcare Medicare & Retirement and UnitedHealthcare Community & State. Optum Health provides comprehensive and patient-centered care, addressing the physical, mental, and social well-being. Optum Health delivers primary, specialty and surgical care and helps patients and providers navigate and address complex, chronic and behavioral health needs. Optum Insight connects the healthcare system with services, analytics and platforms that make clinical, administrative and financial processes simpler and more efficient for all participants in the healthcare system. Optum Rx offers a range of pharmacy care services through retail pharmacies, through home delivery, specialty and community health pharmacies and the provision of in-home and community-based infusion services.
About the author

Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
- Margin Improvement Focus: UnitedHealth is prioritizing profit margin enhancement, indicating a strong commitment to financial health that is expected to positively impact future profitability.
- Stock Performance: As of May 1, 2026, UnitedHealth's stock rose by 0.53%, reflecting market approval of its margin improvement strategy, which may attract more investor interest.
- Market Reaction: The company emphasized its strategic direction in a video, indicating its pursuit of operational optimization to strengthen its position in the highly competitive healthcare industry.
- Long-Term Growth Potential: By focusing on margins, UnitedHealth may achieve sustainable growth in the future, reinforcing its leadership in the healthcare sector.
See More
- Approval Process Simplification: UnitedHealth plans to eliminate the requirement for doctors to obtain approvals for various procedures, tests, and services, which is expected to reduce review numbers by nearly a third, thereby alleviating burdens on both physicians and patients while enhancing healthcare service efficiency.
- Reduction in Review Volume: Currently, about 2% of claims require prior approval, which, while seemingly low, still translates to millions of reviews annually; streamlining this process will help expedite patient treatment timelines significantly.
- Positive Physician Feedback: Physicians have long expressed dissatisfaction with the cumbersome approval process, citing delays and denials in treatment; this initiative by UnitedHealth is likely to improve doctor-patient relationships and enhance patient satisfaction levels.
- Market Reaction Anticipation: This policy change could positively impact UnitedHealth's operational efficiency, further solidifying its leadership position in the U.S. health insurance market, while also potentially influencing its future financial performance.
See More
- Authorization Process Overhaul: UnitedHealthcare has announced the elimination of prior authorization requirements for 30% of healthcare services, reflecting a significant reform aimed at enhancing customer experience and operational efficiency in the managed care sector.
- Industry Positioning: Currently, only 2% of UnitedHealthcare's medical services require prior authorization, with approximately 92% of submitted requests approved within 24 hours, which strengthens its competitive edge in the market.
- Market Ranking Insights: According to Seeking Alpha's Quant Ratings, UnitedHealthcare holds a score of 3.48, placing it mid-pack in the managed healthcare sector, indicating relative stability but highlighting the need to catch up with leaders like Centene and HealthEquity.
- Competitor Landscape: In the managed care space, Centene boasts a Quant Rating of 4.92 with a Strong Buy rating, while UnitedHealthcare and Elevance Health maintain “Hold” ratings, underscoring the competitive pressures and challenges within the industry.
See More
- Increased Market Competition: Amazon's announcement of a new initiative allowing external businesses to utilize its supply chain for deliveries led to significant stock declines for UPS and FedEx, dropping over 10% and 9% respectively, indicating investor concerns about intensified competition in the logistics sector.
- Strong Sales Growth: Palantir reported an impressive 85% revenue growth in Q1, with net income approximately quadrupling year-over-year, showcasing its robust performance in the defense technology sector and projecting a doubling of its U.S. business in the coming year.
- Tesla and SEC Settlement: Tesla CEO Elon Musk reached a settlement with the SEC, agreeing to pay $1.5 million in penalties over allegations of failing to disclose his Twitter stake prior to acquisition, although this minor fine is not expected to have a significant financial impact on the company.
- GLP-1 Market Dynamics: Novo Nordisk's Wegovy pill has rapidly gained tens of thousands of new users within four months of launch, while Eli Lilly's competing Foundayo has seen a more modest uptake, reflecting a shift in market demand for weight-loss medications.
See More
- Market Uncertainty Intensifies: Rising tensions in the Middle East have led to surging oil prices, causing the Dow Jones Industrial Average to drop over 550 points on Monday, marking its worst performance in more than a month, which has left investors concerned about future market sentiment.
- Palantir Surpasses Expectations: Palantir reported an 85% revenue growth in Q1, with net income nearly quadrupling year-over-year, and anticipates its U.S. business will double again next year, raising its full-year free cash flow guidance to $4.2 billion to $4.4 billion, indicating strong market demand and growth potential.
- Tesla Settles with SEC: Tesla CEO Elon Musk has agreed to pay $1.5 million to the SEC to settle allegations of failing to disclose his stake in Twitter before its acquisition, which, if approved by the judge, could alleviate legal risks for Musk and potentially have a positive impact on Tesla's stock price.
- Amazon's New Logistics Initiative: Amazon announced a new initiative allowing external businesses to utilize its supply chain networks for deliveries, which has raised concerns about increased competition with UPS and FedEx, leading to stock declines of over 10% and 9% respectively, reflecting market apprehension about the new competitive landscape.
See More
- Authorization Policy Change: UnitedHealth announced it will eliminate prior authorization requirements for 30% of healthcare services, which is expected to ease administrative burdens for doctors and improve accessibility, as currently only about 2% of services require authorization.
- Future Plans: By the end of 2026, the company plans to eliminate another 30% of remaining approvals, including some outpatient surgeries and diagnostic tests, aiming to streamline processes and accelerate treatment in response to doctors' criticisms of cumbersome paperwork.
- Digital Investment: UnitedHealth is investing in digital tools and artificial intelligence to enable faster decision-making and real-time tracking, with expectations that over 70% of authorizations will follow a new standardized electronic process by year-end, further enhancing efficiency.
- Market Reaction: Despite a 0.3% drop in UNH shares during pre-market trading, retail sentiment shifted to 'bearish', indicating cautious attitudes towards the company's future, although UNH shares have gained approximately 12% so far in 2026.
See More











